On Monday, 1st of June 2026, 2:00 PM (Ljubljana/Berlin time), Assit. Prof. Peter Brazada from the Center for Translational Immunology of the University Medical Center Utrecht , will present in our CTGCT Science Talks webinar series.
Title: From 3D Co-Culture Models to Multimodal Tumor Immunology Workflows
Fill up the form to register and receive the link to the webinar on the day of the talk. The webinar will be recorded and it might be shared partially or fully online.
Assistant Professor Peter Brazda obtained his PhD in Molecular Biology and Biophysics from the University of Debrecen. There he applied quantitative live-cell and single-molecule microscopy to study the dynamic behavior of nuclear receptors during transcription regulation. He then joined the laboratory of prof. Nynke Dekker at TU Delft as a postdoctoral researcher, where he used super-resolution microscopy to investigate replication machinery dynamics and transcription-replication conflicts in bacteria at the single molecule level. A growing fascination with large-scale genomic methods and their medical potential drew him to the group of prof. Henk Stunnenberg at Radboud University and subsequently the Prinses Máxima Center for Pediatric Oncology, where he built expertise in single-cell transcriptomic profiling, working on pheochromocytoma and pediatric AML. He gained experience spanning biophysics, molecular biology, genomics, and quantitative computational approaches to study cellular heterogeneity and complex biological processes. This path led him to transition into computational biology, where he now applies data-driven methods to unravel the complexity of tumor-immune interactions. As assistant professor at the Center for Translational Immunology of the University Medical Center Utrecht, his research centers on understanding how tumor cells and immune cells interact and why immunotherapies succeed in some patients but fail in others. Working in the group of Zsolt Sebestyen and Jürgen Kuball, he investigates tumor heterogeneity, the tumor microenvironment, and the mechanisms underlying gamma-delta and engineered T-cell responses, combining 3D co-culture model systems with multimodal tumor immunology workflows.
In this talk, he will present how 3D co-culture models, combined with multimodal tumor immunology workflows, can be used to study tumor–immune interactions and therapy response in complex microenvironments. He will discuss how these platforms help identify actionable mechanisms to improve next-generation T-cell therapies.